Fundz

Key Proteo reported raising $2.33 Million in an initial SEC Form D filing, from an offering of $2.5 Million

PRIVATEOct 23, 2026Late filing, first sale Mar 25, 2026

Amount Raised

$2.33 Million

$2.33 Million sold, per SEC Form D (first sale Mar 25, 2026)

Round Type

Seed

SeattleBiotechnology

Who to call at Key Proteo, and when

A new round usually means Key Proteo is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Key Proteo raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Key Proteo, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Key Proteo

Location

720 BROADWAY

Seattle, Washington, United States

About

Current newborn screenings cannot detect many treatable genetic diseases, which can become fatal without effective and early treatment. Key Proteo’s ultimate goal is to dramatically improve and expand the current Newborn Screening programs and subsequently provide early intervention of genetic diseases before they are clinically manifested. Key Proteo is specialized in multiplex analysis for any extremely low abundance proteins from a few drops of blood (DBS) using surrogate peptide markers by mass spectrometry. With this new technology, we target new or existing genetic conditions to change their clinical course and ensure better quality of life for our patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Key Proteo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Key Proteo's next move

See what Strategic adds

Key Proteo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.